W. Pridmore, “Updates from the fray: rational off-label and over-the-counter prescribing in amyotrophic lateral sclerosis”, rrnmf, vol. 2, no. 1, pp. 36–40, Feb. 2021, doi: 10.17161/rrnmf.v2i1.14789.